We’ve recently updated our valuation analysis.

Synektik Spólka Akcyjna Valuation

Is SNT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

[object Object] Score


Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SNT?

Other financial metrics that can be useful for relative valuation.

SNT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA9.6x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does SNT's PE Ratio compare to its peers?

The above table shows the PE ratio for SNT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average16.5x
MDA MedApp
VOX Voxel
MRC Mercator Medical
4320 CE HoldingsLtd
SNT Synektik Spólka Akcyjna

Price-To-Earnings vs Peers: SNT is expensive based on its Price-To-Earnings Ratio (23.7x) compared to the peer average (16.5x).

Price to Earnings Ratio vs Industry

How does SNT's PE Ratio compare vs other companies in the European Healthcare Services Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a25.5%

Price-To-Earnings vs Industry: SNT is good value based on its Price-To-Earnings Ratio (23.7x) compared to the European Healthcare Services industry average (32.4x)

Price to Earnings Ratio vs Fair Ratio

What is SNT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SNT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SNT's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of SNT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SNT (PLN29.7) is trading above our estimate of fair value (PLN8.19)

Significantly Below Fair Value: SNT is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies